Bifido

BIFIDO Co., Ltd. is a South Korean microbiome research company founded in 1999, dedicated to the research and development of Bifidobacterium-based probiotic and pharmabiotic products. The company has focused on human-derived Bifidobacterium strains—particularly Bifidobacterium bifidum, B. longum, and B. lactis—accumulating over 260 scientific publications and 74 patents. BIFIDO's integrated platform covers strain discovery through full-scale commercial manufacturing, supporting probiotics, pharmabiotics, and health analysis services. The company provides ODM services to global customers and operates production facilities in Hongcheon, Gangwon Province, with R&D centers in Gyeonggi Province. BIFIDO is listed on the KOSDAQ exchange (238200) and employs approximately 51–100 people.